Shares of Lantheus Holdings (NASDAQ:LNTH) fell ~4% on Tuesday after Truist downgraded the radiopharmaceutical company to Hold from Buy, citing concerns over its Q2 2025 financials, which missed Street forecasts last week.

Analyst Richard Newitter argued that LNTH stock could